FDA Panel Backs First 'Biosimilar' Drug

An FDA advisory panel unanimously recommended the agency approve the first “biosimilar” drug in the U.S., a version of the cancer drug Neupogen.



from WSJ.com: US Business http://ift.tt/1zUQRaR

via IFTTT